Target based virtual screening by docking into automatically generated GPCR models

Methods in Molecular Biology

Volumn 914, Issue , 2012, Pages 255-270

  Tautermann, Christofer S ^a  

^a BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

Author keywords

Application of GPCR homology models; GPCR lead identification; GPCR modeling; Virtual ligand screening

Indexed keywords

BIOGENIC AMINE; G PROTEIN COUPLED RECEPTOR; SEROTONIN 1A RECEPTOR;

ARTICLE; CHEMICAL ANALYSIS; COMPUTER PROGRAM; HIGH THROUGHPUT SCREENING; LIGAND BINDING; MOLECULAR DOCKING; MOLECULAR WEIGHT; MOLECULE; PATENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN ANALYSIS; RETROSPECTIVE STUDY; TARGET BASED VIRTUAL SCREENING; WORKFLOW;

EID: 84934434491     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-62703-23-6_15     Document Type: Article

References (50)

1. Lagerstrom MC, Schioth HB (2008) Structural diversity of G protein-coupled receptors and significance for drug discovery. Nat Rev Drug Discov 7:339-357
2. Fredriksson R, Lagerstrom MC, Lundin LG, Schioth HB (2003) The G-protein-coupled receptors in the human genome formfive main families. Phylogenetic analysis, paralogon groups, andfingerprints. Mol Pharmacol 63:1256-1272
3. Chung S, Funakoshi T, Civelli O (2008) Orphan GPCR research. Br J Pharmacol 153:S339-S346
4. Lin SH, Civelli O (2004) Orphan G proteincoupled receptors: targets for new therapeutic interventions. Ann Med 36:204-214
5. Lundstrom K (2006) Latest development in drug discovery on G protein-coupled receptors. Curr Protein Pept Sci 7:465-470
6. Warne T, Serrano-Vega MJ, Baker JG, Moukhametzianov R, Edwards PC, Henderson R et al (2008) Structure of a beta1-adrenergic G-protein-coupled receptor. Nature 454: 486-491
7. Warne T, Moukhametzianov R, Baker JG, Nehme R, Edwards PC, Leslie AGW et al (2011) The structural basis for agonist and partial agonist action on a beta1-adrenergic receptor. Nature 469:241-244
8. Cherezov V, Rosenbaum DM, Hanson MA, Rasmussen SGF, Thian FS, Kobilka TS et al (2007) High-resolution crystal structure of an engineered human beta2-adrenergic G protein coupled receptor. Science 3181258-1265
9. Rasmussen SGF, Choi HJ, Rosenbaum DM, Kobilka TS, Thian FS, Edwards PC et al (2007) Crystal structure of the human beta2 adrenergic G-protein-coupled receptor. Nature 450:383-387
10. Rasmussen SGF, Choi HJ, Fung JJ, Pardon E, Casarosa P, Chae PS et al (2011) Structure of a nanobody-stabilized active state of the beta2 adrenoceptor. Nature 469:175-180
11. Jaakola VP, Griffith MT, Hanson MA, Cherezov V, Chien EYT, Lane JR et al (2008) The 2.6 Angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist. Science 322:1211-1217
12. Wu B, Chien EY, Mol CD, Fenalti G, Liu W, Katritch V et al (2010) Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists. Science 330: 1066-1071
13. Palczewski K, Kumasaka T, Hori T, Behnke CA, Motoshima H, Fox BA et al (2000) Crystal structure of rhodopsin: a G proteincoupled receptor. Science 289:739-745
14. Chien EYT, Liu W, Zhao Q, Katritch V, Won Han G, Hanson MA et al (2010) Structure of the human dopamine D3 receptor in complex with a D2/D3 selective antagonist. Science 330:1091-1095
15. Bhattacharya S, Hall SE, Vaidehi N (2008) Agonist-induced conformational changes in bovine rhodopsin: insight into activation of G-protein-coupled receptors. J Mol Biol 382: 539-555
16. Bhattacharya S, Vaidehi N (2010) Computational mapping of the conformational transitions in agonist selective pathways of a G-protein coupled receptor. J Am Chem Soc 132:5205-5214
17. Xu F, Wu H, Katritch V, Han GW, Jacobson KA, Gao ZG et al Structure of an agonistbound human A2A adenosine receptor. Science 332:322-327
18. Tautermann CS, Pautsch A (2011) The implication of thefirst agonist bound activated G-protein-coupled receptor (GPCR) X-ray structure on GPCR in silico modeling. ACS Med Chem Lett 2:414-418
19. Evers A, Klebe G (2004) Successful virtual screening for a submicromolar antagonist of the neurokinin-1 receptor based on a ligandsupported homology model. J Med Chem 47:5381-5392
20. Kellenberger E, Springael JY, Parmentier M, Hachet-Haas M, Galzi JL, Rognan D (2007) Identification of nonpeptide CCR5 receptor agonists by structure-based virtual screening. J Med Chem 50:1294-1303
21. Sela I, Golan G, Strajbl M, Rivenzon-Segal D, Bar-Haim S, Bloch I et al (2010) G protein coupled receptors-in silico drug discovery and design. Curr Top Med Chem 10: 638-656
22. Becker OM, Marantz Y, Shacham S, Inbal B, Heifetz A, Kalid O et al (2004) G protein-coupled receptors: in silico drug discovery in 3D. Proc Natl Acad Sci U S A 101:11304-11309
23. Bissantz C, Bernard P, Hibert M, Rognan D (2003) Protein-based virtual screening of chemical databases. II. Are homology models of G-protein coupled receptors suitable targets? Proteins 50:5-25
24. Chen JZ, Wang J, Xie XQ (2007) GPCR structure-based virtual screening approach for CB2 antagonist search. J Chem Inf Model 47:1626-1637
25. Evers A, Hessler G, Matter H, Klabunde T (2005) Virtual screening of biogenic amine-binding G-protein coupled receptors: comparative evaluation of protein-and ligand-based virtual screening protocols. J Med Chem 48: 5448-5465
26. Evers A, Klabunde T (2005) Structure-based drug discovery using GPCR homology modeling: successful virtual screening for antagonists of the alpha1A adrenergic receptor. J Med Chem 48:1088-1097
27. Klabunde T, Giegerich C, Evers A (2009) Sequence-derived three-dimensional pharmacophore models for G-protein-coupled receptors and their application in virtual screening. J Med Chem 52:2923-2932
28. McRobb FM, Capuano B, Crosby IT, Chalmers DK, Yuriev E (2010) Homology modeling and docking evaluation of aminergic G protein-coupled receptors. J Chem Inf Model 50:626-637
29. Nowak M, Kolaczkowski M, Pawlowski M, Bojarski AJ (2006) Homology modeling of the serotonin 5-HT1A receptor using automated docking of bioactive compounds with defined geometry. J Med Chem 49:205-214
30. Tikhonova IG, Sum CS, Neumann S, Engel S, Raaka BM, Costanzi S et al (2008) Discovery of novel agonists and antagonists of the free fatty acid receptor 1 (FFAR1) using virtual screening. J Med Chem 51:625-633
31. Kneissl B, Leonhardt B, Hildebrandt A, Tautermann CS (2009) Revisiting automated G-protein coupled receptor modeling: the benefit of additional template structures for a neurokinin-1 receptor model. J Med Chem 52:3166-3173
32. Bissantz C, Schalon C, Guba W, Stahl M (2005) Focused library design in GPCR projects on the example of 5-HT(2c) agonists: comparison of structure-based virtual screening with ligand-based search methods. Proteins 61:938-952
33. Koppen H (2009) Virtual screening-what does it give us? Curr Opin Drug Discov Devel 12:397-407
34. MOE-Molecular Operating Environment (2010) Chemical Computing Group, Montreal. http://www.chemcomp.com/
35. Marti-Renom MA, Stuart AC, Fiser A, Sanchez R, Melo F, Sali A (2000) Comparative protein structure modeling of genes and genomes. Annu Rev Biophys Biomol Struct 29:291-325
36. Sali A, Blundell TL (1993) Comparative protein modelling by satisfaction of spatial restraints. J Mol Biol 234:779-815
37. Cross JB, Thompson DC, Rai BK, Baber JC, Fan KY, Hu Y et al (2009) Comparison of several molecular docking programs: pose prediction and virtual screening accuracy. J Chem Inf Model 49:1455-1474
38. Cummings MD, DesJarlais RL, Gibbs AC, Mohan V, Jaeger EP (2005) Comparison of automated docking programs as virtual screening tools. J Med Chem 48:962-976
39. Verdonk ML, Cole JC, Hartshorn MJ, Murray CW, Taylor RD (2003) Improved proteinligand docking using GOLD. Proteins 52:609-623
40. Eldridge MD, Murray CW, Auton TR, Paolini GV, Mee RP (1997) Empirical scoring functions: I. The development of a fast empirical scoring function to estimate the binding affinity of ligands in receptor complexes. J Comput Aid Mol Des 11:425-445
41. Bissantz C, Folkers G, Rognan D (2000) Protein-based virtual screening of chemical databases. 1. Evaluation of different docking/ scoring combinations. J Med Chem 43:4759-4767
42. Friesner RA, Banks JL, Murphy RB, Halgren TA, Klicic JJ, Mainz DT et al (2004) Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J Med Chem 47:1739-1749
43. Baker D, Sali A (2001) Protein structure prediction and structural genomics. Science 294:93-96
44. The UniProt Consortium (2010) The Universal Protein Resource (UniProt) in 2010. Nucleic Acids Res 38:D142-D148
45. Ballesteros JA, Weinstein H (1995) Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors. Methods Neurosci 25: 366-428
46. Surgand JS, Rodrigo J, Kellenberger E, Rognan D (2006) A chemogenomic analysis of the transmembrane binding cavity of human G-protein-coupled receptors. Proteins 62:509-538
47. Larsson P, Wallner B, Lindahl E, Elofsson A (2009) Using multiple templates to improve quality of homology models in automated homology modeling. Protein Sci 17:990-1002
48. Goodwin JA, Hulme EC, Langmead CJ, Tehan BG (2007) Roof and floor of the muscarinic binding pocket: variations in the binding modes of orthosteric ligands. Mol Pharm 72:1484-1496
49. Lowe JA, Drozda SE, Snider RM, Longo KP, Zorn SH, Morrone J et al (1992) The discovery of (2S,3S)-cis-2-(diphenylmethyl)-N-((2-methoxyphenyl)methyl)-1- azabicyclo(2.2.2) octan-3-amine as a novel, nonpeptide substance P antagonist. J Med Chem 35:2591-2600
50. Bond CS, Schüttelkopf AW (2009) ALINE: a WYSIWYG protein-sequence alignment editor for publication-quality alignments. Acta Cryst D 65:510-512